The study demonstrated potent antiproliferative and apoptotic activities of TH1902 in vitro and greater tumor regression in vivo compared to docetaxel alone, suggesting the potential of sortilin as a target for personalized therapy in cancers where sortilin is overexpressed [19]. Here, SORT1 is linked to cancer.